Thomas Kolben Selected Research

Thomas Kolben Research Topics

Disease

23	Neoplasms (Cancer) 02/2024 - 06/2016
13	Breast Neoplasms (Breast Cancer) 02/2024 - 02/2012
11	Ovarian Neoplasms (Ovarian Cancer) 09/2023 - 06/2016
6	Spontaneous Abortion (Miscarriage) 11/2021 - 01/2018
6	Habitual Abortion (Recurrent Miscarriage) 11/2021 - 01/2018
5	Ovarian Epithelial Carcinoma 01/2022 - 10/2020
4	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2023 - 10/2020
4	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2020
4	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2019
3	Inflammation (Inflammations) 03/2024 - 10/2020
3	Carcinogenesis 09/2023 - 01/2019
3	Uterine Cervical Dysplasia 08/2023 - 01/2017
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2023 - 02/2019
2	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 12/2022 - 10/2019
1	Disease Progression 07/2023
1	Viral Pneumonia 10/2022
1	COVID-19 10/2022
1	Obesity 10/2022
1	Overweight 10/2022
1	Uterine Neoplasms (Uterine Cancer) 08/2020
1	Hydatidiform Mole (Molar Pregnancy) 01/2020
1	Chorioamnionitis 01/2019
1	Rupture 01/2019
1	Abruptio Placentae (Placental Abruption) 01/2019
1	Fetal Distress 01/2019
1	Squamous Intraepithelial Lesions 01/2017
1	Osteoporosis 02/2012

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2018
6	Galectins (Galectin)IBA 03/2024 - 04/2020
6	Messenger RNA (mRNA)IBA 11/2021 - 12/2018
4	Estrogen ReceptorsIBA 09/2023 - 01/2016
4	histone H3 trimethyl Lys4IBA 01/2022 - 08/2020
4	CytokinesIBA 11/2021 - 10/2020
4	ProstaglandinsIBA 12/2020 - 01/2018
3	ParaffinIBA 02/2024 - 07/2020
3	Hormones (Hormone)IBA 02/2024 - 02/2012
3	CateninsIBA 01/2023 - 08/2020
3	Dinoprostone (PGE2)FDA Link 06/2020 - 01/2018
2	Formaldehyde (Formol)FDA Link 02/2024 - 07/2020
2	Co-Repressor ProteinsIBA 09/2023 - 07/2020
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2023 - 01/2018
2	Platelet Activating FactorIBA 01/2023 - 06/2021
2	Sialyl Lewis X AntigenIBA 12/2022 - 01/2017
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 12/2022 - 01/2017
2	Sirtuin 1IBA 01/2022 - 08/2020
2	Mucin-1 (CA 15-3 Antigen)IBA 02/2021 - 01/2020
2	LigandsIBA 01/2021 - 07/2020
2	Interleukin-7 (Interleukin 7)IBA 01/2021 - 10/2020
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2021
2	Vitamin D FDA LinkGeneric 10/2020 - 06/2016
2	FSH Receptors (FSH Receptor)IBA 10/2019 - 06/2019
1	ErbB Receptors (EGF Receptor)IBA 02/2024
1	GTP-Binding Proteins (G-Protein)IBA 09/2023
1	Chemokine CCL22IBA 08/2023
1	RNA Splicing FactorsIBA 07/2023
1	Blood Group Antigens (Blood Groups)IBA 12/2022
1	Insulin (Novolin)FDA Link 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	Galectin 4 (LGALS4)IBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022
1	PlatinumIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	ResveratrolIBA 01/2022
1	Lysine (L-Lysine)FDA Link 11/2021
1	Histones (Histone)IBA 11/2021
1	Interleukin-18 (Interleukin 18)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	EnzymesIBA 06/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 02/2021
1	platelet activating factor receptorIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	GlycodelinIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021
1	rupatadineIBA 01/2021
1	CalciumIBA 10/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2020
1	Nuclear Receptor Co-Repressor 1IBA 07/2020
1	human ERBB2 proteinIBA 01/2020
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2020
1	Galectin 1 (LGALS1)IBA 10/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2019
1	progesterone receptor BIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	progesterone receptor AIBA 01/2019
1	Fas Ligand Protein (Fas Ligand)IBA 02/2018
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018
1	Thyroid HormonesIBA 06/2016
1	Tamoxifen FDA LinkGeneric 02/2012
1	Aromatase InhibitorsIBA 02/2012
1	Diphosphonates (Bisphosphonates)IBA 02/2012

Therapy/Procedure

13	Therapeutics 02/2024 - 02/2012
2	Adjuvant Chemotherapy 02/2024 - 01/2016
1	Contraindications 01/2019
1	Segmental Mastectomy (Lumpectomy) 01/2018
1	Colposcopes 01/2017